Development of an experimental hemolytic uremic syndrome in rats

Pediatric Nephrology

Volumn 23, Issue 4, 2008, Pages 559-567

  Zotta, Elsa ^a   Lago, Nestor ^a   Ochoa, Federico ^a   Repetto, Horacio A ^b   Ibarra, Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL NACIONAL PROFESOR ALEJANDRO POSADAS   (Argentina)

Author keywords

Acutetu bular necrosis; Diarrhea; Hemolytic uremic syndrome; Shiga toxin; Thrombotic microangiopathy

Indexed keywords

CREATININE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM MUTANT; CONTROLLED STUDY; CREATININE CLEARANCE; DIARRHEA; EXPERIMENTAL MODEL; GLOMERULUS FILTRATION RATE; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; HISTOPATHOLOGY; HUMAN VERSUS ANIMAL COMPARISON; KIDNEY INJURY; KIDNEY TUBULE NECROSIS; LEUKOCYTOSIS; MALE; NONHUMAN; OLIGURIA; PERITONEAL DISEASE; PRIORITY JOURNAL; RAT; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINE VOLUME;

ACUTE DISEASE; ANIMALS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; COLON; CREATININE; DIARRHEA; DISEASE MODELS, ANIMAL; HEMOLYTIC-UREMIC SYNDROME; IMMUNOENZYME TECHNIQUES; KIDNEY TUBULES; MALE; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VERO CELLS;

EID: 40549083384     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0727-4     Document Type: Article

References (37)

1. Griffin PM, Tauxe RV (1991) The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13:60-98
2. Remuzzi G, Ruggenenti P (1995) The hemolytic uremic syndrome. Kidney Int 48:2-19
3. Repetto HA (1997) Epidemic hemolytic-uremic syndrome in children. Nephrology Forum. Kidney Int 52:1708-1719
4. Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR (1997) Childhood hemolytic uremic syndrome in Argentina: Long-term follow-up and prognostic features. Pediatr Nephrol 11:156-160
5. Robson WL, Leung AK, Brant R (1993) Relationship of the recovery in the glomerular filtration rate to the duration of anuria in diarrhea-associated hemolytic uremic syndrome. Am J Nephrol 13:194-197
6. Tonshoff B, Sammet A, Sanden I, Mehls O, Waldherr R, Scharer K (1994) Outcome and prognostic determinants in the hemolytic uremic syndrome of children. Nephron 68:63-70
7. Scully RE, Mark EJ, McNeely WF, Ebeling SH, Phillips LD (1995) Case records of the Massachusetts General Hospital. N Engl J Med 336:1587-1594
8. Tarr PI (1995) Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection. Clin Infect Dis 20:1-8
9. Lopez EL, Diaz M, Grinstein S, Devoto S, Mendilaharzu F, Murray BE, Ashkenazi S, Rubeglio E, Woloj M, Vasquez M, Turco M, Pickering LK, Cleary TG (1989) Hemolytic uremic syndrome and diarrhea in Argentine children: The role of Shiga-like toxins. J Infect Dis 160:469-475
10. Rivas M, Balbi L, Miliwebsky ES, Garcia B, Tous MI, Leardini NA, Prieto MA, Chillemi GM, De Principi ME (1998) Hemolytic uremic syndrome in children of Mendoza, Argentina: Association with Shiga-toxin producing Escherichia coli infection. Medicina (B. Aires) 58:1-7
11. Rivas M, Caletti MG, Chinen I, Refi SM, Roldan CD, Chillemi G, Fiorilli G, Bertolotti A, Aguerre L, Estani SS (2003) Home-prepared hamburger and sporadic hemolytic uremic syndrome, Argentina. Emerg Infect Dis 9:1184-1186
12. Rivas M, Milwebsky E, Chinen I, Deza N, Leotta G (2006) The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B. Aires) 66:27-32
13. Exeni R (2001) Síndrome Urémico Hemolítico. Arch Latin Nefr Ped 1:35-56
14. Tesh VL, Burris JA, Owens JW, Gordon VM, Wadolkowski EA, O'Brien AD, Samuel JE (1993) Comparison of the relative toxicities of Shiga-like toxins type 1 and type 2 for mice. Infect Immun 61:3392-3402
15. Zhao YL, Cen XB, Ito M, Yokoyama K, Takagi K, Kitaichi K, Nadai M, Ohta M, Takagi K, Hasegawa T (2002) Shiga-like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats. Antimicrob Agents Chemother 46:1522-1528
16. Sugatani J, Komiyama N, Mochizuki T, Hoshino M (2002) Urinary concentrating defect in rats given Shiga toxin: Elevation in urinary AQP2 level associated with polyuria. Life Sci 71:171-189
17. Keepers T, Psotka M, Gross L, Obrig T (2006) A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404-3414
18. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C (1997) The role of lipopolysaccharide and Shiga like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 175:611-620
19. Siegler Rl, Pysher TJ, Lou R, Tesh VL, Taylor FB Jr (2001) Response to Shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 21:420-425
20. Palermo M, Alves-Rosa F, Rubel C, Fernandez GC, Fernandez-Alonso G, Alberto F, Rivas M, Isturiz M (2000) Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose dependent opposite effects on Shiga toxin-2 lethality. Clin Exp Immunol 119:77-83
21. Louise C, Obrig T (1992) Shiga toxin-associated hemolytic uremic syndrome: Combined cytotoxic effects of Shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60:1536-1543
22. Duner KI (1993) A new kinetic single stage Limulus amoebocyte lysate method for the detection of endotoxin in water and plasma. J Biochem Biophys Methods 26:131-142
23. Fujii J, Kinoshita Y, Yutsudo T, Taniguchi H, Obrig T, Yoshida SI (2001) Toxicity of Shiga toxin 1 in the central nervous system of rabbits. Infect Immun 69:6545-6548
24. Pistone Creydt V, Silberstein C, Zotta E, Ibarra C (2006) Cytotoxic effect of Shiga toxin-2 holotoxin and its B subunit on human renal tubular epithelial cells. Microbes Infect 8:410-419
25. Pistone Creydt V, Miyakawa MF, Martin F, Zotta E, Silberstein C, Ibarra C (2004) The Shiga toxin 2B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops. Braz J Med Biol Res 37:799-808
26. Dean-Nystrom EA, Melton-Celsa AR, Pohlenz JF, Moon HW, O'Brien AD (2003) Comparative pathogenicity of Escherichia coli O157 and intimin-negative non-O157 Shiga toxin-producing E. coli strains in neonatal pigs. Infect Immun 71:6526-6533
27. Gunzer F, Hennig-Pauka I, Waldmann KH, Sandhoff R, Grone HJ, Kreipe HH, Matussek A, Mengel M (2002) Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli. Am J Clin Pathol 118:364-375
28. Imai Y, Fukui T, Kurohane K, Miyamoto D, Suzuki Y, Ishikawa T, Ono Y, Miyake M (2003) Restricted expression of Shiga toxin binding sites on mucosal epithelium of mouse distal colon. Infect Immun 71:985-990
29. Pruimboom-Brees I, Morgan T, Ackermann M, Nystrom E, Samuel J, Cornick N, Moon H (2000) Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxins. Proc Natl Acad Sci USA 97:10325-10329
30. Taylor FB Jr, Tesh VL, DeBault L, Li A, Chang AC, Kosanke SD, Pysher TJ, Siegler RL (1999) Characterization of the baboon responses to Shiga-like toxin: Descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol 154:1285-1299
31. Pohlenz JF, Winter KR, Dean-Nystrom EA (2005) Shiga-toxigenic Escherichia coli -inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome. Infect Immun 73:612-616
32. Rutjes N, Binnington B, Smith C, Maloney M, Lingwood L (2002) Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model. Kidney Int 62:832-845
33. Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60:831-846
34. Richardson SE, Karmali MA, Becker LE, Smith CR (1988) The histopathology of the hemolytic uremic syndrome (HUS) associated with verocytotoxin producing Escherichia coli infections. Hum Pathol 19:1102-1108
35. Kato G, McGowan V, Machado R, Little J, Taylor J VI, Morris C, Nichols J, Wang X, Poljakovic M, Morris Jr S, Gladwin M (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107:2279-2285
36. Brain MC (1970) Microangiopathic hemolytic anemia. Annu Rev Med 21:133-144
37. Donato H, Rendo P, Exeni R, Rapetti MC, Antonuccio M, Galvagni A, Grimoldi I, Exeni A (1997) Erythropoietin deficiency in children with acute renal insufficiency due to hemolytic uremic syndrome. Hematología (B. Aires) 1:5-11